Wei-guo Zhu
Chaigoubu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Chemoradiotherapy with or Without Anlotinib for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: A Real-World Observational Study.
Journal: Drug design, development and therapy
Published: June 02, 2025
Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy.
Journal: Frontiers in oncology
Published: January 18, 2021
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
Journal: Radiation oncology (London, England)
Published: September 24, 2020
Ellagic acid induces esophageal squamous cell carcinoma cell apoptosis by modulating SHP-1/STAT3 signaling.
Journal: The Kaohsiung journal of medical sciences
Published: January 20, 2020
Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Journal: The oncologist
Published: October 25, 2018
Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer.
Journal: OncoTargets and therapy
Published: May 08, 2018
High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.
Journal: Experimental cell research
Published: July 10, 2017
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Journal: Scientific reports
Published: August 22, 2016
High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Journal: Molecular carcinogenesis
Published: August 06, 2015
A randomized controlled trial of intensity-modulated radiation therapy plus docetaxel and cisplatin versus simple intensity-modulated radiation therapy in II-III stage esophageal carcinoma
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: September 25, 2013
Application of simplified intensity modulated radiation therapy in gastric cancer after operation
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: March 29, 2013
Last Updated: 09/26/2026